Lifetime risk for developing congestive heart failure: the Framingham Heart Study - PubMed (original) (raw)
Lifetime risk for developing congestive heart failure: the Framingham Heart Study
Donald M Lloyd-Jones et al. Circulation. 2002.
Abstract
Background: Congestive heart failure (CHF) is an increasing public health problem.
Methods and results: Among Framingham Heart Study subjects who were free of CHF at baseline, we determined the lifetime risk for developing overt CHF at selected index ages. We followed 3757 men and 4472 women from 1971 to 1996 for 124 262 person-years; 583 subjects developed CHF and 2002 died without prior CHF. At age 40 years, the lifetime risk for CHF was 21.0% (95% CI 18.7% to 23.2%) for men and 20.3% (95% CI 18.2% to 22.5%) for women. Remaining lifetime risk did not change with advancing index age because of rapidly increasing CHF incidence rates. At age 80 years, the lifetime risk was 20.2% (95% CI 16.1% to 24.2%) for men and 19.3% (95% CI 16.5% to 22.2%) for women. Lifetime risk for CHF doubled for subjects with blood pressure >/=160/100 versus <140/90 mm Hg. In a secondary analysis, we only considered those who developed CHF without an antecedent myocardial infarction; at age 40 years, the lifetime risk for CHF was 11.4% (95% CI 9.6% to 13.2%) for men and 15.4% (95% CI 13.5% to 17.3%) for women.
Conclusions: When established clinical criteria are used to define overt CHF, the lifetime risk for CHF is 1 in 5 for both men and women. For CHF occurring in the absence of myocardial infarction, the lifetime risk is 1 in 9 for men and 1 in 6 for women, which highlights the risk of CHF that is largely attributable to hypertension. These results should assist in predicting the population burden of CHF and placing greater emphasis on prevention of CHF through hypertension control and prevention of myocardial infarction.
Comment in
- A lifetime of prevention: the case of heart failure.
Yusuf S, Pitt B. Yusuf S, et al. Circulation. 2002 Dec 10;106(24):2997-8. doi: 10.1161/01.cir.0000046804.13847.5d. Circulation. 2002. PMID: 12473540 No abstract available. - One in 5 at risk for congestive heart failure.
SoRelle R. SoRelle R. Circulation. 2002 Dec 10;106(24):e9066-7. doi: 10.1161/01.cir.0000051635.04584.21. Circulation. 2002. PMID: 12473571 No abstract available.
Similar articles
- Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study.
Haider AW, Larson MG, Franklin SS, Levy D; Framingham Heart Study. Haider AW, et al. Ann Intern Med. 2003 Jan 7;138(1):10-6. doi: 10.7326/0003-4819-138-1-200301070-00006. Ann Intern Med. 2003. PMID: 12513039 - Incidence and epidemiology of heart failure.
Kannel WB. Kannel WB. Heart Fail Rev. 2000 Jun;5(2):167-73. doi: 10.1023/A:1009884820941. Heart Fail Rev. 2000. PMID: 16228142 Review. - The progression from hypertension to congestive heart failure.
Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. Levy D, et al. JAMA. 1996 May 22-29;275(20):1557-62. JAMA. 1996. PMID: 8622246 - Lifetime risk for development of atrial fibrillation: the Framingham Heart Study.
Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, D'Agostino RB, Massaro JM, Beiser A, Wolf PA, Benjamin EJ. Lloyd-Jones DM, et al. Circulation. 2004 Aug 31;110(9):1042-6. doi: 10.1161/01.CIR.0000140263.20897.42. Epub 2004 Aug 16. Circulation. 2004. PMID: 15313941 - The risk of congestive heart failure: sobering lessons from the Framingham Heart Study.
Lloyd-Jones DM. Lloyd-Jones DM. Curr Cardiol Rep. 2001 May;3(3):184-90. doi: 10.1007/s11886-001-0021-1. Curr Cardiol Rep. 2001. PMID: 11305971 Review.
Cited by
- Sex difference in human diseases: mechanistic insights and clinical implications.
Shi Y, Ma J, Li S, Liu C, Liu Y, Chen J, Liu N, Liu S, Huang H. Shi Y, et al. Signal Transduct Target Ther. 2024 Sep 10;9(1):238. doi: 10.1038/s41392-024-01929-7. Signal Transduct Target Ther. 2024. PMID: 39256355 Free PMC article. Review. - Clinical profile, treatment patterns and one-year outcome of heart failure patients admitted in tertiary care hospital of North India.
Shah UA, Rashid A, Mufti SA, Khan S, Qazi ZM, Masoom I, Khuja ZA, Bukhari I, Kakroo SA, Rather H. Shah UA, et al. J Family Med Prim Care. 2024 Aug;13(8):3225-3230. doi: 10.4103/jfmpc.jfmpc_1868_23. Epub 2024 Jul 26. J Family Med Prim Care. 2024. PMID: 39228559 Free PMC article. - Complete percutaneous coronary revascularization: An elegant solution to left ventricular dysfunction caused by severe coronary artery disease.
Milutinovic S, Singh K, Oluic S, Lopez-Mattei JC, Escárcega RO. Milutinovic S, et al. Clin Case Rep. 2024 Aug 5;12(8):e9224. doi: 10.1002/ccr3.9224. eCollection 2024 Aug. Clin Case Rep. 2024. PMID: 39104738 Free PMC article. - Association between cardiac time intervals and incident heart failure after acute coronary syndrome.
Bjerregaard CL, Olsen FJ, Skaarup KG, Jørgensen PG, Galatius S, Pedersen S, Iversen A, Biering-Sørensen T. Bjerregaard CL, et al. Int J Cardiovasc Imaging. 2024 Aug 3. doi: 10.1007/s10554-024-03206-8. Online ahead of print. Int J Cardiovasc Imaging. 2024. PMID: 39096406 - Calcineurin-NFAT dynamics correspond to cardiac remodeling during aortic banding and debanding, mimicking aortic valve replacement.
Lunde IG, Skrbic B, Sjaastad I, Christensen G, Carlson CR, Tønnessen T. Lunde IG, et al. Front Mol Med. 2022 Oct 25;2:980717. doi: 10.3389/fmmed.2022.980717. eCollection 2022. Front Mol Med. 2022. PMID: 39086965 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical